Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 12.

Journal Article

Braun, M., Gluz, O., Nitz, U., Christgen, M., Kuemmel, S., Schumacher, C., Potenberg, J., Kraemer, S., Kleine-Tebbe, A., Augustin, D., Aktas, B., Forstbauer, H., Tio, J., Liedtke, C., Kates, R. E., Wuerstlein, R., Kreipe, H. -H. and Harbecks, N. (2016). Final analysis of WSG-ADAPT HER2+/HR+ phase-II-trial - efficacy, safety and predictive markers for 12-weeks of neoadjuvant T-DM1 with or without endocrine therapy versus Trastuzumab plus endocrine therapy in HER2-positive hormone-receptor-positive early breast cancer. Oncol. Res. Treat., 39. S. 2 - 3. BASEL: KARGER. ISSN 2296-5262

Friedrich, M., Swords, D., Altgassen, C., Baum, S. and Kraemer, S. (2016). Alloplastic breast reconstruction after mastectomy. Eur. J. Gynaecol. Oncol., 37 (5). S. 622 - 627. MONTREAL: I R O G CANADA, INC. ISSN 0392-2936

Gluz, O., Nitz, U., Christgen, M., Kates, R., Clemens, M., Kraemer, S., Nuding, B., Aktas, B., Kuemmel, S., Reimer, T., Lorenz-Salehi, F., Krabisch, P., Just, M., Augustin, D., Liedtke, C., Svedman, C., Shak, S., Wuerstlein, R., Kreipe, H. and Harbeck, N. (2016). Prospective WSG phase III PlanB trial: Clinical outcome at 5 year follow up and impact of 21 Gene Recurrence Score result, central/local-pathological review of grade, ER, PR and Ki67 in HR+/HER2-high risk node-negative and -positive breast cancer. Eur. J. Cancer, 57. S. S6 - 1. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

Gluz, O., Nitz, U., Kreipe, H. H., Christgen, M., Kates, R. E., Hofmann, D., Shak, S., Clemens, M., Kraemer, S., Aktas, B., Kuemmel, S., Reimer, T., Kusche, M., Heyl, V., Lorenz-Salehi, F., Just, M., Liedtke, C., Wuerstlein, R. and Harbeck, N. (2015). Clinical impact of risk classification by central/local grade or luminal-like subtype vs. Oncotype DX (R): First prospective survival results from the WSG phase III planB trial. Eur. J. Cancer, 51. S. S311 - 1. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

Harbeck, N., Gluz, O., Christgen, M., Braun, M., Kuemmel, S., Schumacher, C., Potenberg, J., Kraemer, S., Kleine-Tebbe, A., Augustin, D., Aktas, B., Forstbauer, H., Tio, J., Liedtke, C., Kates, R. E., Wuerstlein, R., de Haas, S. L., Kiermaier, A., Kreipe, H. H. and Nitz, U. (2016). Final analysis of WSG-ADAPT HER2+/HR+ phase II trial: Efficacy, safety, and predictive markers for 12-weeks of neoadjuvant TDM1 with or without endocrine therapy versus trastuzumab plus endocrine therapy in HER2-positive hormone-receptor positive early breast cancer. Cancer Res., 76. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445

Harbeck, N., Nitz, U. A., Matthias, C., Kates, R., Braun, M., Kummel, S., Schumacher, C., Potenberg, J., Kraemer, S., Kleine-Tebbe, A., Augustin, D., Aktas, B., Forstbauer, H., Tio, J., Liedtke, C., Grischke, E-M, de Haas, S. L., Deurloo, R., Schumacher, J., Wuerstlein, R., Kreipe, H. H. and Gluz, O. (2017). The role of immune and apoptosis markers for prediction of pCR in the WSG-ADAPT HER2+/HR+ phase II trial evaluating 12-weeks of neoadjuvant TDM1 +/- endocrine therapy (ET) versus T + ET in HER2-positive hormone-receptor-positive early breast cancer (EBC). Cancer Res., 77. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445

Kraemer, S., Malter, W., Lange, N., Fridrich, C. and Mallmann, P. (2014). Targeted breast surgery - classification of oncoplastic techniques. Oncol. Res. Treat., 37. S. 16 - 17. BASEL: KARGER. ISSN 2296-5262

Liedtke, C., Gluz, O., Heinisch, F., Feuerhake, F., Kreipe, H. H., Clemens, M., Nuding, B., Kraemer, S., Reimer, T., Svedman, C., Shak, S., Nitz, U., Kates, R. E., Harbeck, N. and Christgen, M. (2016). Association of TILs with clinical parameters, recurrence score, and prognosis in patients with early HER2-negative breast cancer (BC) A translational analysis of the prospective WSG planB trial. Cancer Res., 76. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445

Malter, W., Kapteina, S., Thangarajah, F., Markiefka, B., Bongartz, R., Semrau, R., Hellmich, M., Kraemer, S. and Mallmann, P. (2014). Intraoperativeassessment of macroscopic instantaneous sections to prevent re-resection in IORT patients. Oncol. Res. Treat., 37. S. 16 - 17. BASEL: KARGER. ISSN 2296-5262

Malter, W., Kirn, V., Bongartz, R., Semrau, R., Markiefka, B., Mallmann, P. and Kraemer, S. (2014). Single center experiences with intraoperative radiotherapy as a boost during oncoplastic breast-conserving surgery. Oncol. Res. Treat., 37. S. 15 - 17. BASEL: KARGER. ISSN 2296-5262

Nitz, U., Gluz, O., Kreipe, H., Christgen, M., Kates, R. E., Clemenss, M., Kraemer, S., Aktas, B., Kuemmel, S. and Harbeck, N. (2015). Risk assessment by St.Gallen 2013 recommendation and Oncotype DX (R): results from the WSG PlanB trial. Breast, 24. S. S110 - 1. EDINBURGH: CHURCHILL LIVINGSTONE. ISSN 1532-3080

Nitz, U., Gluz, O., Kreipe, H., Christgen, M., Kates, R. E., Clemenss, M., Kraemer, S., Aktas, B., Kuemmel, S. and Harbeck, N. (2015). Risk assessment by St.Gallen 2013 recommendation and Oncotype DX (R): results from the WSG PlanB trial. Breast, 24. S. S110 - 1. EDINBURGH: CHURCHILL LIVINGSTONE. ISSN 1532-3080

This list was generated on Sun May 9 02:59:05 2021 CEST.